Corporate news
Grifols receives FDA approval for its new purification plant to produce Gamunex in Los Angeles The plant, located in Los Angeles (California), represents an investment of 53 million euros, and over 100 new jobs will be created when it starts operation in 2015
+ info
+ info
Grifols contributes to river restoration projects Restoring the course of the River Tenes and a study of the reintroduction of otters are the focus of a cooperation agreement with the Consortium for the Protection of the River Besós Basin
+ info
+ info
Grifols introduces new 40-g IVIG vial size for GAMUNEX-C The widest range of vial sizes expands convenience options for Ig therapy
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
New transfusion medicine solutions
Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info
